Home / News / Global News / US Student Sues GlaxoSmithKline International. See Why (Photos)

US Student Sues GlaxoSmithKline International. See Why (Photos)


Khaliah Shaw, a graduate student at Georgia College and State University in the US has suffered a rare skin disorder that causes her skin to peel off.

For this, the 26-year old student is reportedly suing UK pharmaceutical giant GlaxoSmithKline (GSK) after claiming she received the wrong dosage of a medication that caused her skin to burn off.

Within weeks of taking the drug, Ms Shaw claims blisters broke out over her body. She told the news outlet she was “in excruciating pain” and felt like she was “on fire”.

Ms Shaw spent five weeks in a medically induced coma while her skin slowly peeled off. She told the news outlet that the syndrome left her skin scarred and she is slowly losing her vision, while her fingernails might never grow back.

The syndrome has no cure and doctors told her she might relapse.

“They’re telling me this could happen again, and they’re telling me if it did happen again, that it would be worse,” Ms Shaw told 11Alive.

Ms Shaw is now suing the drug manufacturer GSK for promoting the product without warning of the risks, reportedly demanding more than $3.45m (£2.68m).
Read more

According to the Independent.co.uk, it is not the first time the drug company has been sued for alleged health care fraud.

In 2012, GSK agreed to pay $3bn and pleaded guilty to criminal charges of illegally marketing drugs and withholding safety data from US regulator, the Food and Drug Administration (FDA).

Earlier this month, a US jury in Chicago ruled that GSK must pay $3m to a woman who sued the firm after her husband committed suicide while taking a generic version of the antidepressant Paxil. The drug company is appealing the decision.

Check Also


Vice Chancellor Set to Re-Position Unijos

UNIVERSITY of Jos, situated in the heart of Jos, has had its fair share of …

Leave a Reply

Your email address will not be published. Required fields are marked *

Please wait...

Subscribe to our newsletter

Want to be notified when our article is published? Enter your email address and name below to be the first to know.